REXN Shares Outstanding History



Below is a table of the REXN shares outstanding history going back to 5/10/2019:

Date REXN Shares Outstanding
5/10/20194.02M
6/10/20194.02M
8/7/20194.02M
8/2/2019103.86M
11/6/20194.02M
2/21/20204.02M
4/29/20204.02M
5/7/20204.02M
8/14/20204.23M
10/29/20204.48M

Also see: REXN Market Cap History
REXN YTD Return
REXN Historical Shares Outstanding:
+7.69% CAGR
REXN Historical Shares Outstanding: +7.69% CAGR

Mouse over chart for data details
5/10/2019 ...10/29/2020
Rexahn Pharmaceuticals is clinical stage biopharmaceutical company developing therapies to improve patient outcomes in cancers. Co.'s pipeline features two oncology product candidates in clinical development and additional compounds in pre-clinical development. Co.'s drug candidates are: RX-3117, which is an investigational oral small molecule nucleoside compound that provides the potential for a targeted anti-cancer therapy; RX-5902, which is a small molecule modulator that modulates the pathway via inhibition of phosphorylated p68 which hinders the transport of beta-catenin into the nucleus and reduces the activation of cancer genes; and RX-0301, which is a potential potent inhibitor. We show 10 historical shares outstanding datapoints in our coverage of REXN's shares outstanding history.

Understanding the changing numbers of REXN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like REXN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching REXN by allowing them to research REXN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree REXN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Rexahn Pharmaceuticals (REXN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

RGEN Shares Outstanding History
RGLS Shares Outstanding History
RGNX Shares Outstanding History
RIGL Shares Outstanding History
RLAY Shares Outstanding History
RLMD Shares Outstanding History
RLYB Shares Outstanding History
RMD Shares Outstanding History
RMED Shares Outstanding History
RMTI Shares Outstanding History
More Healthcare companies »

 

REXN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.